Xcell Biosciences, Inc. — Form D
Xcell Biosciences, Inc. of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-17. The offering totals $3.5M, of which $1.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-12-17
- Form: D
- Accession: 0001697666-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $1.4M
- Remaining: $2.1M
- Minimum investment: $50K
- Investors: 5
- Date of first sale: 2024-12-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-532362
Issuer
- Name: Xcell Biosciences, Inc.
- CIK: 0001697666
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 455 Mission Bay Blvd S, Suite 124, San Francisco, CA, 94158
- Phone: 415-937-0321
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Saeid S Akhtari | Director | San Francisco, CA |
| Brian S Feth | Director | San Francisco, CA |
| Brian S Feth | Executive Officer | San Francisco, CA |
| James S Lim | Executive Officer | San Francisco, CA |
| Kaz S Ohno | Executive Officer | San Francisco, CA |
| James Lim | Executive Officer | Owings Mills, MD |
| Kaz Ohno | Executive Officer | San Francisco, CA |
| Brian Feth | Director | San Francisco, CA |
| Brian Feth | Executive Officer | San Francisco, CA |
| Saeid Akhtari | Director | San Francisco, CA |
Other filings by this issuer (2)
More